BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'Transient receptor potential cation channel subfamily V member 1' and Ligand = 'BDBM142722'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Transient receptor potential cation channel subfamily V member 1


(Homo sapiens (Human))
BDBM142722
PNG
(US8937092, 22)
Show SMILES CC(C(=O)NCc1ccc(cc1-c1cccc(C)c1)C(F)(F)F)c1ccc(CNS(C)(=O)=O)c(F)c1
Show InChI InChI=1S/C26H26F4N2O3S/c1-16-5-4-6-19(11-16)23-13-22(26(28,29)30)10-9-20(23)14-31-25(33)17(2)18-7-8-21(24(27)12-18)15-32-36(3,34)35/h4-13,17,32H,14-15H2,1-3H3,(H,31,33)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
23n/an/an/an/an/an/an/an/a



Gruenenthal GmbH

US Patent


Assay Description
The FLIPR protocol consists of 2 substance additions. First the compounds to be tested (10 uM) are pipetted onto the cells and the Ca2+ influx is com...


US Patent US8937092 (2015)


BindingDB Entry DOI: 10.7270/Q27S7MG3
More data for this
Ligand-Target Pair